Skip to main content
main-content
Top

The PIONEER 6 trial

Update 06-11-2019 | Oral semaglutide falls just short of cardioprotection in event-driven PIONEER 6

Presenters: John B. Buse, MD, PhD; Vanita R. Aroda, MD; Richard E. Pratley, MD; Stephen C. Bain, MA, MD, FRCP; Mansoor Husain, MD, FRCPC; Ofri Mosenzon, MD, MSc; Vivian Fonseca, MD.

Tuesday 11 June: 9:45–11:45

The positive topline results of the PIONEER 6 cardiovascular safety trial were press released late last year, but the full results are to be presented at the American Diabetes Association's 79th Scientific Sessions (ADA 2019). The investigators will also review data from the rest of the PIONEER program, outlining oral semaglutide’s efficacy and safety.

More on this trial